Vor Biopharma Aktie - VOR

Professionelle Tools für Privatanleger.

Premium

Current Price

1,1093

Gebot

1,00

Fragen

1,40

Volumen

816.926

1,05 Tagesbereich 1,23

0,6354 52-Wochen-Bereich 3,1399

Marktkapitalisierung

76,18M

Handelsende

1,19

Handelsbeginn

1,23

Letzte Trade

240

1.1093

(formt)

Letzter Handelszeitpunkt

Finanzvolumen

US$ 904.818

VWAP

1,1076

Durchschnittliches Volumen (3 Mio.)

643.684

Ausgegebene Aktien

68.673.612

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,64

Gewinn pro Aktie (EPS)

-1,72

Erlöse

Nettogewinn

-117,86M

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.vorbio.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was US$1,19. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0,6354 to US$ 3,1399.

Vor Biopharma currently has 68.673.612 shares in issue. The market capitalisation of Vor Biopharma is US$81,72 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.64.

Form 8-K - Current report

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

Form 8-K - Current report

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.2493	28.988372093	0.86	1.35	0.82	2273328	1.22421261	CS
4	0.2293	26.0568181818	0.88	1.35	0.8	964356	1.09629538	CS
12	0.3993	56.2394366197	0.71	1.35	0.6354	643684	0.94902037	CS
26	0.0793	7.69902912621	1.03	1.35	0.6354	712482	0.91842073	CS
52	-1.1407	-50.6977777778	2.25	3.1399	0.6354	521769	1.1845799	CS
156	-10.7007	-90.6071126164	11.81	12.73	0.6354	264210	2.42592091	CS
260	-40.9107	-97.3600666349	42.02	63.62	0.6354	241417	6.25302185	CS

VOR - Frequently Asked Questions (FAQ)

What is the current Vor Biopharma share price?

The current share price of Vor Biopharma is US$ 1,1093

How many Vor Biopharma shares are in issue?

Vor Biopharma has 68.673.612 shares in issue

What is the market cap of Vor Biopharma?

The market capitalisation of Vor Biopharma is USD 81,72M

What is the 1 year trading range for Vor Biopharma share price?

Vor Biopharma has traded in the range of US$ 0,6354 to US$ 3,1399 during the past year

What is the PE ratio of Vor Biopharma?

The price to earnings ratio of Vor Biopharma is -0,64

What is the reporting currency for Vor Biopharma?

Vor Biopharma reports financial results in USD

What is the latest annual profit for Vor Biopharma?

The latest annual profit of Vor Biopharma is USD -117,86M

What is the registered address of Vor Biopharma?

The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Vor Biopharma website address?

The website address for Vor Biopharma is www.vorbio.com

Which industry sector does Vor Biopharma operate in?

Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
BDMDBaird Medical Investment Holdings Ltd	US$ 7,6699 (630,47%)	89,74M
APMAptorum Group Ltd	US$ 2,799 (106,57%)	116,74M
COEPCoeptis Therapeutics Holdings Inc	US$ 5,44 (75,48%)	5,08M
VRMEVerifyMe Inc	US$ 1,332 (68,63%)	94,04M
VEEETwin Vee PowerCats Company	US$ 0,55 (53,59%)	5,62M
WATTEnergous Corporation	US$ 1,00 (-62,26%)	29,33M
SGMOSangamo Therapeutics Inc	US$ 1,02 (-56,41%)	44,56M
INTZIntrusion Inc	US$ 3,07 (-45,95%)	15,07M
KZIAKazia Therapeutics Ltd	US$ 1,78 (-42,58%)	708,99k
TOIIWOncology Institute Inc	US$ 0,0052 (-42,22%)	366,02k
SVMHSRIVARU Holding Ltd	US$ 0,0423 (26,65%)	794,74M
XTIAXTI Aerospace Inc	US$ 0,0422 (6,84%)	446,31M
EYENEyenovia Inc	US$ 0,1474 (30,10%)	412,83M
CRKNCrown Electrokinetics Corporation	US$ 0,146899 (5,91%)	402,05M
ONCOOnconetix Inc	US$ 0,6479 (48,26%)	270,47M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Vor Biopharma Inc (VOR) Börsenkurse

Vor Biopharma Inc (VOR)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Vor Biopharma Inc

VOR Neueste Nachrichten

VOR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen